The Effectiveness of Telemedicine Solutions in Type 1 Diabetes Management: A Systematic Review and Meta-analysis
Pooled result · HbA1cResult — go to the resultMean difference −0.26 % 95% CI −0.37% to −0.15%Authors' conclusion
Reducing average HbA1c% levels are important to combat the risk of diabetic complications and premature death. However, the evidence mostly consist of small studies with a relative short duration and the estimated pooled effect is smaller than could be expected from quality improvement strategies in general for diabetes management.
Study context
- Population
- Adults (≥18 years) with T1D; studies published before October 14, 2020
- Participants
- 1,615 adults22 studies
- Comparison
- Telemedicine solutions vs any comparator
- Outcome
- HbA1c (%)
Methodological detailsGRADE certainty assessment, Cochrane risk-of-bias tool
- GRADE certainty assessment
- Cochrane risk-of-bias tool
Pooled result
HbA1c
Mean difference
−0.26 %
95% CI −0.37% to −0.15%
Telemedicinevs Any comparator
mean difference −0.26 % (95% CI −0.37% to −0.15%)
As reported in the abstract
- Heterogeneity (I2)
- 33.30%
Further pooled results
Secondary outcomes
- Not significant; all favoured telemedicine except number of severe hypoglycaemic events and diabetes knowledge; certainty low or very low
Original publication
The Effectiveness of Telemedicine Solutions in Type 1 Diabetes Management: A Systematic Review and Meta-analysis. J Diabetes Sci Technol. Published 9 February 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →